Atovaquone 250 mg proguanil hydrochloride 100 mg
1 INDICATIONS AND USAGE Atovaquone and proguanil hydrochloride tablets are an antimalarial indicated for: • prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. ( 1.1 ) • treatment of acute, uncomplicated P. falciparum malaria. ( 1.2 ) 1.1 Prevention of Malaria Atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. 1.2 Treatment of Malaria Atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated P. falciparum malaria. Atovaquone and proguanil hydrochloride tablets have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.
Mylan Pharmaceuticals Inc.
ROUND PINK M AP 2
Related Pills
Atovaquone 62.5 mg proguanil hydrochloride 25 mg
Mylan Pharmaceuticals Inc.
Atovaquone 250 MG proguanil hydrochloride 100 MG Oral Tablet
Mylan Pharmaceuticals Inc.
Atovaquone 62.5 MG proguanil hydrochloride 25 MG Oral Tablet
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE Tablets are available containing 250 mg of atovaquone, USP and 100 mg of proguanil hydrochloride, USP. The 250 mg/100 mg tablets are buff, film-coated, round, unscored tablets debossed with A-P over 2 on one side of the tablet and M on the other side. They are available as follows: NDC 0378-4162-01 bottles of 100 tablets
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE Pediatric Tablets are available containing 62.5 mg of atovaquone, USP and 25 mg of proguanil hydrochloride, USP. The 62.5 mg/25 mg tablets are buff, film-coated, round, unscored tablets debossed with A-P over 1 on one side of the tablet and M on the other side. They are available as follows: NDC 0378-4160-01 bottles of 100 tablets Storage Conditions: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like ROUND M AP 2